Previously, split-thickxiess hutnan skin grafted onto athymic mice has been sho-wn to become markedly hyperpigmented, but the factor(s) responsible for this hyperpigmentation had not been isolated. The present study describes the isolation and characterization of a potent melanogenic inhibitor from grafted human skin. Extracts from grafted skin inhibited, in a concentration-dependent manner, tyrosinase activity of normal human melanocytes and of Cloudman S91 niurine melanoma in culture. Sodium dodecylsulfate-polyacrylamide gel electrophoresis analysis of extracts from pre-and post-grafted skin demonstrated the presence of a protein doublet of approximately 14 kD exclusively in the post-grafted skin. This protein inhibited both tyrosinase activity and cellular proliferation in a concentration-dependent manner. The inhibition of tyrosinase activity in normal human melanocytes was 53% at 0.5 /ig/ml concentration, whereas this inhibition w^as almost complete in murine melanoma cultures at 1.0 jLig/ml. The protein did not inhibit either cellular proliferation or protein synthesis in normal human fibroblast cultures, and therefore may act specifically on melanocytes. Injections of the inhibitor corresponded w^ith a delay and reduction in the quantity of pigment in human skin 2 weeks after grafting. Multiple injections of the inhibitor into the hyperpig^mented xenografts (20 w^eeks after grafting) reversed the hyperpigmentation w^ith no observable inflammatory or toxic responses. The results indicate that hyperpigmented human skin xenografts contain a potent inhibitor of melanogenesis and melanocyte proliferation. Key words: athymic mice. J Invest Dermatol 104:739-743, 1995 P revious studies from other institutions [1, 2] and from this laboratory [3] have indicated that human skin xenografts on athymic mice undergo marked hyperpigmentation. The pigmentation seems to he greater in meshes or split-thickness grafts than in fuU-thickiiess grafts [3] , At present, the exact molecular mechanism of this hyperpigmentation is not known. It was reported recently that the density and size of dihydroxyphenylalanine (DOPA)-positive melanocytes were significantly increased after grafting [3] . Concomitant with tliis increase, elevated levels of known inelanogenic enzymes and melanogenic peptides were also observed [4] . However, the mechanisms by which cellular proliferation and melanogenic activation are stimulated are not known.
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To define the molecular mechanisms for tliis hyperpigmentation, we investigated the molecule(s) responsible for tliis phenomenon. First, the presence of a potent melanogenic inhibitor present exclusively in the grafted human skin was identified. This inhibitor profoundly blocks both melanogenesis and cellular proliferation in culture. The present study describes the isolation, biochemical characterization, and biologic activity of this melanogenic inhibitor 1/ 1 vivo and iti vitro.
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MATERIALS AND METHODS

Skin Grafting
Procedures for grafting liuman skin onto athymic mice (nu/nu, albino Balb/C) have been described previously [3] and were approved by the University of Cincinnati Institutional Animal Care and Use Committee. Briefly, murine skin was excised, and split-thickness skin graft was sutured to wound punctures. At selected times after grafting (usually 12-15 weeks), the grafted mice were sacrificed using an overdose of Nembutol and the grafts were removed.
Extraction of Proteins from Skin
Both pre-and post-grafted sldn was cut into small pieces after removal of subcutaneous fat. Twenty percent (wt/vol) skin homogenates were prepared in phosphate-buffered saline containing 1 niM phenylmethylsulfonyl fluoride using a motorized homogenizer (Polytron; Brinkman, Westbury, NY). After centrifugation at 2000 X g for 20 mill, the supernatant was collected and centrifuged again at 100,000 X g for 1 h to obtain clear soluble fraction. Both crude extract and supernatant were filter sterilized, and protein content was detcnnined by the Bradford method [5] .
Treatment of Cell Cultures with Skin Extract and Measurement of Tyrosinase Activity
The culture conditions for nonnal human melanocytes [6] from neonatal foreskin and for Cloudman S91 melanoma cells [7] were similar to those descrihed previously.
In a typical cell culture experiment, cells were inoculated at a density of 1.5 X 10" cells into six-well plates containing the respective media for human melanocytes or Cloudman S91 cells. Forty-eight hours later, media in all wells were replaced with fresh media containing increasing concentrations of pre-or post-grafted skin supernatant and/or electroeluted proteins (mean = three per condition). Between 48 and 72 h of the experiment, fresh media containing ['HJtyrosine (1 /j,Ci/ml) plus supemataiits or isolated proteins were added to the cultures. The conditioned medium fi-om each well was used to determine the secreted tyrosine 
739
hydroxylase activity of tyrosinase, according to a modification of the Pomerantz charcoal absorption lnethod as described previously [8] [9] [10] . Cell counts per well were determined by Coulter counter. Triplicate wells were used for each experimental condition (mean = three per condition). Responses of cell proliferation by human melanocytes or Cloudman S91 cells were studied hy measuring the rates of ["*H]thymidine incorporation according to a previous study [7] .
Sodium Dodecylsulfate-polyacrylamide Gel Electrophoresis (SDS-PAGE) and Electroelution of Proteins from Gel Skin extracts (50 fxg protein) were subjected to SDS-PAGE using the discontinuous buffer system described by Laemmli [11] in 15% slab gel. After separation, the proteins were stained with a 0.05% wt/vol solution of Coomassie brilliant blue R-250. In some cases in which the separated proteins had to be electroeluted fi-om the gels, only a part of the gel along witb molecular-weight standards was cut out and stained. After destaining, both stained and unstained gels were aligned side by side, and the protein band of interest was excised fi-om the unstained gel for electroelution. Proteins fi-om the excised portions of the gel were eluted in buffer containing Tris (20 mM), glycine (150 mM), and SDS (0.05%). Electroelution was performed in an electrophoretic chamber (Schleicher & Schuell) at 150 V overnight. The fractions were collected, concentrated, and dialyzed by Centricon-3 (Amicon Corporation). The concentrated fi-actions were then filter sterilized, and protein contents were determined.
In Vivo Characterization of Electroeluted Proteins
Proteins electroeluted fi-om SDS gels were analyzed for their effects on hyperpigmented athymic mice (nu/nu) (20 weeks and 2 weeks after grafting). The animals were divided into two groups: the experimental group (A), with five mice, and the control group (B), including two mice. In group A, 50 (xl containing approximately 2 ug of protein was injected subcutaneously into a circled area of the graft at weekly intervals. Five such injections were given on the left side of the grafted mice. As an internal control, 50 p.1 of normal saline was injected on the right side of the same graft. In group B, no injection was given, and tliis condition provided baseline values for melanocyte counts. Biopsies were done in both groups at time 0 and 1 week after the final injection; specimens were processed for counting DOPA-positive melanocytes and for routine light microscopy to visualize any morphologic changes after the injections. Photographs were taken every week to assess any change of color in the skin graft.
RESULTS
Inhibition of Tyrosinase Activity in Normal Hutnan Melanocytes Treated with Grafted Skin Extract
Treatment of normal human melanocyte cultures with increasing concentrations of post-grafted skin extract (ranging from 25 to 100 ^g/ml) resulted in an early increase in tyrosinase activity at lower concentrations of skin protein (25 ^g/ml), followed by a concentrationdependent inhibition at higher concentrations. Compared with control, approximately 50% of tyrosinase activity was inhibited at 100 fxg/ml. Cells treated with pre-grafted skin extract showed no significant inhibition of tyrosinase activity (Fig 1) . A similar pattern of inhibition was observed with murine melanoma S91 cells.
Presence of 14-kD Protein in Post-Grafted Human Skin
Extracts and Supernatants To identify specific stimulatory or inhibitory proteins associated with pre-and post-grafted skin, we performed SDS-PAGE analyses of crude extracts. As shown in Fig  2, there was no major difference between pre-grafted crude extract and supernatant {lane 1 versus lane 2) and between post-grafted skin extract and supernatant {lane 3 versus lane 4). However, comparisons of pre-and post-grafted skin showed differences in protein patterns. The protein in pre-grafted skin of approximately 50 kD and 66 kD probably represents albumin. Another significant difference was the presence of a doublet of approximately 14 kD present exclusively in the post-grafted skin {lanes 3, 4) . A fraction extracted with Triton X-100 did not contain this protein, an indication that it is a soluble protein {lane 5).
14-kD Protein firom Post-Grafted Skin Inhibits Tyrosinase
Activity in Normal Human Melanocytes Because the major difference between pre-and post-grafted skin was the presence of a 14-kD band, we studied its effect on tyrosinase activity in normal human melanocytes. This protein was electroeluted from multiple gels and added to the cell cultures at concentrations of 0.25 and O'^O fig/ml. The supernatant from pre-grafted skin was run under identical conditions, and the gel corresponding to the of 14-kD molecular-weight marker or 14-kD band was cut '^^ fraction was electroeluted to ensure that the observed only due to the 14-kD band and was not from the py gel huffer. As shown in Table I , the addition of variot*^ concentrations of 14-kD protein from post-grafted skin result^'i in a concentration-dependent inliibition of tyrosinase activity-This inhibition was 53% at 0.5 jag/ml concentration. No 5jj^j0cant inhibition was observed when electroeluted fraction from pre-grafted skin was added to the cultures.
Protein Inhibits Tyrosinase Activity and Cell Prolif-
Murine Melanoma Cells The effect of 14-kD isolated from post-grafted skin on melanogenesis in murine cells was also determined. The cell cultures were treated ifferent concentrations of 14-kD protein ranging from 0.25 to ""'-^* shown in Fig 3, a concentration-dependent inhihityrosinase activity was observed, and the inhibition was complete (90%) at 1,0 /xg/ml concentration. A minimal tyrosinase activity was seen in the presence of the electroeluted from the pre-grafted skin. Cell proliferation incorporation) was also reduced significantly in the of 14-kD protein (Fig 4) , examine whether the 14-kD protein isolated from postskin was specific for melanogenic enzyme and was not a metabolic inhibitor, we studied its effect on cultured normal fibroblasts. Incubation of normal liuman fibroblasts with up higher concentration of the protein (0.25 to 2,5 /xg/ml) 
resulted in no inhibition of either [•'HJthymidine or incorporation (data not shown). of
In Vivo Characterization of 14-kD Protein The 14-kD band into 20 weeks post-grafted nude mice resulted j^j g marked reduction in the number of DOPA-positive melanocyj^s The extent of reduction in melanocytes ranged fironi 9% to 32% (Xable II). Parallel to this decrease, skin color was also reduc^j gj the site of injection. In contrast, no change in either DOPA-posj^jye melanocytes or skin color was ohserved when the grafts Vvere injected with normal saline. Microscopic analysis of histoV^gij-changes after injection of protein and/or normal saline was pg|-_ formed in a blinded manner. Based on hematoxylin and ^i stahiing patterns, no difference between experimental and control animals was observed. There was no injury pattern in either the epidermis or dermis and no evidence of toxicity or inflammation. These results indicate that the electroeluted 14-kD protein when injected in vivo selectively inhibits melanocyte proliferation without caushig histologic damage to epidermal cells. To confirm further the inhibitory effect of the 14-kD protein on melanocyte proliferation in vu'O, we studied human skin 2 weeks after grafting to athymic mice. These skin samples also showed a similar reduction in DOPA-positive melanocytes, which persisted throughout the experimental period.
DISCUSSION
The present study was performed to isolate and characterize the biologic factor(s) responsible for the observed hyperpigmentation. The stimulation of tyrosinase and cellular proliferation in these melanocyte cultures in the presence of extracts was monitored to assess the presence of stimulatory factor. An initial stimulation of tyrosinase activity and cell proliferation at lower concentration suggests the presence of a stimulatory factor, whereas at liigher concentrations, inhibition of both tyrosinase activity and cellular proliferation indicates the presence of a melanogenic inhibitor in grafted skin.
Comparison of the protein profiles between pre-and postgrafted skin extracts revealed the presence of a doublet of approximately 14 kD exclusively in post-grafted skin. This protein has a potent inhibitory effect on pigmentation. Although a protein of similar molecular weight was also found in normal skin from nude mice, that protein had no effect on melanogenesis. Initial biochemical studies have indicated that the inhibitor is sensitive to protease treatment or ionic detergents, is thermolabile, and is completely inactivated at 100°C within 5 min. This is the first report of the presence of a potent melanogenic inhibitor in grafted human skin. This molecule is unique because it is a natural product of human skin. Initial in vivo studies of the isolated protein on early (2 weeks) and late (20 weeks) grafted athymic mice suggested that the protein has a significant inhibitory effect, with no morphologic or anatomic changes to the grafted skin. A number of reports have described the presence of melanogenic inhibitors [12] [13] [14] [15] , At present, none of these inhibitors have been isolated or characterized rigorously. Recent studies by Kameyama ct al [16] indicated the presence of a potent melanogenic inhibitor in nonpigmented murine JB/MS melanoma tumor cells. That inhibitor acts on tyrosinase to suppress melanin production dramatically. The identity and nature of that inhibitor has not yet been completely characterized. However, preliminary data suggest that unlike the melanogenic inhibitor reported here, that inhibitor is not sensitive to protease treatment or ionic detergents, but is inactivated by reducing agents. Recently, a post-tyrosinase inhibitor of melanogenesis, called blocking factor, has been described in S91 melanoma cells [17, 18] . That factor blocks the conversion of 5,6-dihydroxyindole to indole 5,6 quinone and is lost after treatment of the cells with melanocyte-stimulating hormone. In another study, an inhibitor localized in the melanin granule fraction of S91 cells was described [19] . In addition, two large groups of melanogenic inhibitors have been documented. The first group of inhibitors did not affect isolated tyrosinase but was found to inhibit tyrosinase synthesis and its glycosylation, thereby suppressing melanogenesis in living cell systems [20] . The second group of inhibitors is effective in both isolated tyrosinase and living cellsuppression systems [21] . Recently, Mishima [22] isolated low-, middle-, and high-molecular-weight inhibitors called a (A&B), j3, and y, with a^ A intrinsic inhibitor less than 6000 kD molecular weight. The a, A intrinsic inhihitor was later identified as lactic acid [22] , Lactic acid markedly inliibits tyrosinase isoenzymes, particularly T2 and T^ in B-16 cells, which suggests that it inhibits tyrosinase synthesis rather than directly suppressing the enzyme itself.
The presence of melanization-inhibiting factor activity in the ventral skin of an amphibian Xcnoptis lac vis has been reported [23] . Subsequent studies demonstrated the presence of melanizationinhibiting factor activity in other species of frogs and suggested that this factor might play an important role in dorsal-ventral pigment pattern formation [24, 25] . Unlike the inhibitor described here, that inhibitor has a molecular weight of approximately 450 kD. In addition to melanization-inhihiting factor, Fukuzawa cl al reported a higher-molecular-weight inhibitor of approximately 1500 kD from frog skin, which inhibits severely both neural crest cell outgrowth and melanoblast differentiation."!"
The identification of a melanogenic inhibitor in hyperpigmented skin grafts was unexpected. Rather, a potent melanogenic stimulator was anticipated. We speculate that this inhibitor may function as a feedback control in heavily melanized skin and that the relative ratios of melanogenic stimulators to inhihitors determines the ultimate melanogenic outcome: hyperpigmentation or hypopigmentation. If this is the case, then this would explain why inflammation results in either post-inflammatory hyper-or hypopigmentation. The melanogenic inhibitor that we have isolated might eventually be useful clinically for the treatment of various hyperpigmentary disorders. " Animals in group A were injected subcutaneously with 50 j U. 1 containing 2 /xg of electroeluted proteins. Five such injections were given at weekly intervals on the left side of 20 weeks grafted mice. Similarly, the injections of normal saline were given on the right side of the graft in the same mice. Skin biopsies were taken hefore and after fmal injections. and DOPA-positive melanocytes were counted. In group B, no injections were given. Biopsies were taken before study and at 5 weeks to obtain baseline counts for DOPA-positive melanocytes. Data expressed as mean ± SD.
